IRIS
DANESE, Silvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.774
EU - Europa 3.798
AS - Asia 2.308
AF - Africa 611
SA - Sud America 79
Continente sconosciuto - Info sul continente non disponibili 44
OC - Oceania 44
Totale 27.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.563
SG - Singapore 1.331
FI - Finlandia 1.013
IE - Irlanda 704
CN - Cina 631
NG - Nigeria 592
FR - Francia 406
DE - Germania 403
GB - Regno Unito 225
NL - Olanda 223
IT - Italia 207
CA - Canada 199
SE - Svezia 187
TR - Turchia 101
BE - Belgio 90
IL - Israele 72
IN - India 63
RU - Federazione Russa 62
RO - Romania 46
A2 - ???statistics.table.value.countryCode.A2??? 41
AU - Australia 38
BR - Brasile 38
PL - Polonia 36
CL - Cile 35
ES - Italia 34
CZ - Repubblica Ceca 30
JP - Giappone 29
UA - Ucraina 26
GR - Grecia 23
IR - Iran 23
AT - Austria 17
NO - Norvegia 16
BD - Bangladesh 12
EG - Egitto 12
CH - Svizzera 9
HK - Hong Kong 9
MD - Moldavia 9
MX - Messico 8
DK - Danimarca 7
LT - Lituania 7
NZ - Nuova Zelanda 6
AE - Emirati Arabi Uniti 5
IQ - Iraq 4
KR - Corea 4
MY - Malesia 4
SA - Arabia Saudita 4
AR - Argentina 3
EU - Europa 3
GT - Guatemala 3
HU - Ungheria 3
MO - Macao, regione amministrativa speciale della Cina 3
PT - Portogallo 3
AL - Albania 2
MK - Macedonia 2
PK - Pakistan 2
TN - Tunisia 2
VE - Venezuela 2
ZA - Sudafrica 2
BG - Bulgaria 1
BY - Bielorussia 1
CO - Colombia 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LV - Lettonia 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
Totale 27.658
Salva come PNG Salva come JPEG
Città #
Chandler 4.195
Wilmington 4.032
San Mateo 1.633
Ann Arbor 1.257
Helsinki 1.013
Singapore 810
Lawrence 713
Princeton 713
Leawood 703
Dublin 701
Boardman 698
Benin City 589
Ashburn 492
Shanghai 469
Paris 389
New York 387
Woodbridge 378
Fairfield 364
Amsterdam 213
London 160
Toronto 157
Seattle 142
Norwalk 103
San Diego 93
Kocaeli 92
Brussels 84
Phoenix 78
Milan 68
Santa Clara 50
Redwood City 46
Los Angeles 36
Monmouth Junction 36
Falls Church 34
Abbiategrasso 33
Clearwater 33
Pune 33
Cambridge 29
Brno 25
Houston 25
Moscow 25
Des Moines 24
Redmond 21
Beijing 19
Falkenstein 19
Tappahannock 17
Munich 15
Ottawa 15
Frankfurt am Main 14
Warsaw 14
Las Vegas 13
Gunzenhausen 11
Raleigh 11
Andover 9
Chisinau 9
Duncan 9
Hanover 9
La Canada Flintridge 9
Novokuznetsk 9
St Louis 9
Vienna 9
Zhengzhou 9
Dallas 8
Kemerovo 8
Buffalo 7
Cairo 7
Sacramento 7
Cupertino 6
Henderson 6
Hyderabad 6
Reghin 6
Tokyo 6
Valencia 6
Brisbane 5
Genoa 5
Istanbul 5
Leipzig 5
Pitesti 5
Saint Louis 5
Sunderland 5
Sydney 5
Washington 5
Winnipeg 5
Apo 4
Athens 4
Auckland 4
Damietta 4
Glasgow 4
Hangzhou 4
Köln 4
Madrid 4
Melbourne 4
Mumbai 4
Rome 4
Saint Paul 4
San Pedro 4
Seoul 4
São Paulo 4
Vancouver 4
Adliswil 3
Alexandria 3
Totale 21.598
Salva come PNG Salva come JPEG
Nome #
Biological agents for ulcerative colitis : Hypes and hopes 256
Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion 200
Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial 154
Crohn's disease 84
Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease 83
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis 78
Darvadstrocel for the treatment of patients with perianal fistulas in Crohn's disease 74
Evolving strategies and goals of treatment in ulcerative colitis 72
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 71
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 71
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations 70
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 70
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer 70
Laparoscopic Surgery for Recurrent Crohn's Disease 69
Adalimumab in ulcerative colitis: Ready for prime time 69
Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment 69
Risk of postoperative recurrence and postoperative management of Crohn's disease 67
New Drug Delivery Systems in Inflammatory Bowel Disease: MMX (TM) and Tailored Delivery to the Gut 67
Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice 66
Budesonide : teaching an old dog new tricks for inflammatory bowel disease treatment 65
Thrombomodulin-activated protein C-endothelial protein C receptor pathway: A novel anti-inflammatory system in IBD 65
A Prospective Comparison Between Computerized Tomography (CT) and Magnetic Resonance (MR) in Ileo-Colonic Crohn's Disease: A Single-Center Experience. 65
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 64
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 64
Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients 64
Methotrexate for Corticosteroid- Dependent Ulcerative Colitis: Results of a Placebo Randomized Controlled Trial 64
A liophylized and inactivated colture of Lactobacillus acidophilus increases Helicobacter pylori eradication rate 64
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 63
Intestinal microbiota in inflammatory bowel disease: Friend of foe? 62
A NEW TOOL FOR PRE-COLONOSCOPY DYING OF THE COLONIC MUCOSA WITH ORAL MULTI MATRIX RELEASE TECHNOLOGY (MMX (R))-RELEASED METHYLENE BLUE: A PRELIMINARY STUDY 62
Colitis-associated cancer: the dark side of inflammatory bowel disease 62
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre study. 62
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 62
IBD Of mice and men-shedding new light on IL-13 activity in IBD 61
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis 61
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 61
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 60
Adalimumab is effective in achieving clinical and endoscopic long-term deep remission : a case report 59
Dysregulated intracellular redox equilibrium in intestinal lamina propria T cells (LPT) contributes to mucosal inflammation 59
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study 59
Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine? 59
Association between Helicobacter pylori CagA-positive strains and ischemic stroke. 59
Adalimumab in active ulcerative colitis: A "real-life" observational study 59
Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients 58
The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes 58
Review article: optimal preparation for surgery in Crohn's disease 58
Balanced propofol sedation administered by nonanesthesiologists : the first Italian experience 58
JAK inhibitors: Novel developments in management of ulcerative colitis 58
Ulcerative Colitis 58
Effect of Tumor Necrosis Factor-alpha Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease 58
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 58
Perception of reproductive health in women with inflammatory bowel disease 58
Impact of Tumour Necrosis Factor Antagonists on Avoiding Surgery in Stricturing Crohn's Disease: A Tertiary Center Real-Life Experience 57
A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies 57
Second-Generation Corticosteroids for the Treatment of Crohn's Disease and Ulcerative Colitis: More Effective and Less Side Effects? 57
ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer 57
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis 57
Meta-Analysis of the Association Between Anti-Tumour Necrosis Factor Use and Lymphoma Risk in Patients With Inflammatory Bowel Disease: Methodological Considerations 56
Regulatory T-Cell Therapy for Crohn's Disease: In Vivo Veritas 56
Review article: causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-alpha therapy 56
Internet use among inflammatory bowel disease patients: an Italian multicenter survey 56
Accuracy of a new diagnostic tool in deep infiltrating endometriosis: Positron emission tomography-computed tomography with 16 alpha-[18F]fluoro-17 beta-estradiol 56
Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease 56
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 56
Accuracy of Diffusion-weighted Magnetic Resonance Imaging in Detecting Mucosal Healing and Treatment Response, and in Predicting Surgery, in Crohn's Disease 56
Emerging biologics in the treatment of inflammatory bowel disease : what is around the corner? 55
Anemia in Inflammatory Bowel Disease: The Opening of Pandora's Box? 55
Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome 55
Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study 55
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter? 55
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial 55
Folate in gastrointestinal health and disease 55
WallFlex colonic stent placement for management of malignant colonic obstruction : a prospective study at two centers 55
Quality of Care in Ulcerative Colitis: A Modified Delphi Panel Approach 55
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study 55
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials 55
Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go 55
Surgical rates in the era of biological therapy: up, down or unchanged? 54
Enhanced platelet adhesion induces angiogenesis in the IBD microcirculation 54
Efficacy and safety of biologic agents and tofacitinib in moderate-to-severe ulcerative colitis: A systematic overview of meta-analyses 54
Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply 54
Ustekinumab in the management of Crohn's disease: Expert opinion 54
Helicobacter pylori infection in rheumatoid arthritis - Reply 54
Correlation between delta(CO2)-C-13 excretion and prevalence of dyspeptic symptoms in subjects evaluated for H. pylori infection by C-13-urea breath test 54
Effect of Oral Administration of Methylene Blue MMx (R) Tablets on Double-Stranded DNA Damage Assessed by gamma H2AX Analysis of Colon Biopsy Samples - A Single Center, Open Label, Safety, Phase II Study 54
Association between Helicobacter pylori cytotoxic type I strains and migraine with aura 54
Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome. 54
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease 53
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 53
High prevalence of infection by H. pylori cytotoxic type I strains in recurrent spontaneous abortion 53
Microscopic features of colorectal neoplasia in inflammatory bowel diseases 53
When can unfractionated heparin really be useful in the treatment of ulcerative colitis? 53
Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation 53
The CD40/CD40L costimulatory pathway in inflammatory bowel disease 53
Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease A Systematic Review and Meta-Analysis of Randomized Controlled Trials 53
Stopping infliximab in crohn's disease: Still an ongoing STORI 53
Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis 53
Adalimumab in Crohn's disease : tips and tricks after 5 years of clinical experience 53
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease 53
Is cytotoxic-associated gene A-positive Helicobacter pylori important? 52
Totale 6.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 246.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 246.978
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202094 0 0 0 0 0 0 0 0 0 0 2 92
2020/20217.428 40 114 49 76 36 2.221 1.007 529 1.484 982 25 865
2021/20224.321 216 55 132 871 39 48 127 555 391 708 944 235
2022/202310.525 1.608 443 1.060 1.208 899 954 32 942 1.830 867 553 129
2023/20245.145 439 531 1.153 220 179 616 231 277 98 90 425 886
2024/2025847 223 196 74 214 140 0 0 0 0 0 0 0
Totale 28.360